🔎 Trials Near Me

홈 › 전립선암 › 펜실베이니아

펜실베이니아의 전립선암 임상 시험

전립선암 관련 연구 64개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.

펜실베이니아의 도시

공식 연구 텍스트(영어)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Pocono Medical Center, East Stroudsburg
  • 외 8개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

  • Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 28. 업데이트됨 · NCT06095089

DESTINY-PANTUMOUR04

  • Research Site, Philadelphia
피험자 모집 중관찰 연구
18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • MidLantic urology ( Site 0022), Bala-Cynwyd
  • Fox Chase Cancer Center ( Site 0076), Philadelphia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • MidLantic urology, Bala-Cynwyd
  • The Centers for Advanced Urology d/b/a Keystone Urology Specialist, Lancaster
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 24. 업데이트됨 · NCT07028853

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 22. 업데이트됨 · NCT07213674

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Fox Chase Cancer Center, Philadelphia
피험자 모집 중2/3상
18세 ~ 100세 · 남성 · 2026. 9. 22. 업데이트됨 · NCT06780670

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

  • Research Site, Hershey
  • Research Site, Lancaster
  • Research Site, Pittsburgh
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 18. 업데이트됨 · NCT06952803

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
피험자 모집 중2상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
  • Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 17. 업데이트됨 · NCT06925737

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

  • GSK Investigational Site, Philadelphia
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 9. 16. 업데이트됨 · NCT07332455

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  • Thomas Jefferson University, Philadelphia
  • University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 남성 · 2026. 9. 15. 업데이트됨 · NCT07493512

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
  • WellSpan York Cancer Center, York
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • MidLantic Urology, Bala-Cynwyd
피험자 모집 중
18세 이상 · 남성 · 2026. 9. 14. 업데이트됨 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • UPMC-Heritage Valley Health System Beaver, Beaver
  • Carlisle Regional Cancer Center, Carlisle
  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • 외 24개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 10. 업데이트됨 · NCT05946213

Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients

  • Wellspan, Chambersburg
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06138067

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Saint Vincent Hospital, Erie
  • Jefferson Hospital, Jefferson Hills
  • Forbes Hospital, Monroeville
  • 외 8개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 9. 2. 업데이트됨 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • 외 7개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

A Study of Tarlatamab for People With Prostate Cancer

  • Thomas Jefferson University Hospital, Philadelphia
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 31. 업데이트됨 · NCT07111507

Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

  • Penn State Cancer Institute, Hershey
피험자 모집 중1/2상
40세 이상 · 남성 · 2026. 8. 31. 업데이트됨 · NCT06600698

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Pittsburgh
피험자 모집 중3상
18세 이상 · 남성 · 2026. 8. 26. 업데이트됨 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • Lancaster Urology, Lancaster
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 24. 업데이트됨 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Thomas Jefferson University, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 남성 · 2026. 8. 21. 업데이트됨 · NCT04221542

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
피험자 모집 중2상
18세 이상 · 남성 · 2026. 8. 21. 업데이트됨 · NCT06844383

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • UPMC Altoona, Altoona
  • UPMC-Heritage Valley Health System Beaver, Beaver
  • Carlisle Regional Cancer Center, Carlisle
  • 외 26개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 8. 19. 업데이트됨 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Pennsylvania, Perelman School of Medicine, Philadelphia
  • University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • Penn State Milton S. Hershey Medical Center, Hershey
  • Thomas Jefferson University Honickman Center, Philadelphia
  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 ~ 100세 · 남성 · 2026. 8. 13. 업데이트됨 · NCT05519449

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • IRMC Cancer Center, Indiana
  • UPMC Hillman Cancer Center - New Castle, New Castle
  • 외 2개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07059884

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Thomas Jefferson University, Philadelphia
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 31. 업데이트됨 · NCT06613100

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

  • Investigative Site #109, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 23. 업데이트됨 · NCT06545942

PSMA PET Combined With MRI for the Detection of PCa

  • MidLantic Urology, Philadelphia
피험자 모집 중3상건강한 지원자 환영
18세 이상 · 남성 · 2026. 7. 23. 업데이트됨 · NCT07052214

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Christiana Care Health System-Concord Health Center, Chadds Ford
  • Geisinger Medical Center, Danville
  • Geisinger Cancer Center Dickson City, Dickson City
  • 외 6개
피험자 모집 중3상
18세 이상 · 남성 · 2026. 7. 14. 업데이트됨 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • MidLantic Urology, Bala-Cynwyd
  • Keystone Urology Specialists, Lancaster
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 9. 업데이트됨 · NCT05413421

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

  • Thomas Jefferson University, Philadelphia
  • University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 남성 · 2026. 7. 2. 업데이트됨 · NCT07140900

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  • Thomas Jefferson University Hospital, Philadelphia
피험자 모집 중1/2상
18세 이상 · 남성 · 2026. 6. 25. 업데이트됨 · NCT06457919

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia
피험자 모집 중2상
18세 이상 · 남성 · 2026. 6. 15. 업데이트됨 · NCT05422911

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • University of Pittsburg Medical Center (UPCM), Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT05283330

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT04890613

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Univ of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중4상
18세 ~ 100세 · 남성 · 2026. 6. 4. 업데이트됨 · NCT05803941

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.